Document:

Exhibit 10.4

 

  

 

 

LETTER OF
AGREEMENT

Date: October 20, 2015

 

Section 1.  Services to be
Rendered. The purpose of this letter is to set forth the terms and conditions on which Chord Advisors, LLC (“Chord”)
agrees to provide Ritter Pharmaceuticals, Inc. (the “Company”) technical financial accounting advisory services.
Chord will depend on the Company to provide information needed to perform the services and will rely on the Company for the accuracy
and completeness of such information.

 

Section 2.  Engagement Period.
Unless sooner terminated as provided herein, the term of this agreement (the “Engagement Period”) shall
commence on November 1, 2015 and shall continue until terminated by either party. The Company represents that it is duly
organized, validly existing and in good standing under the laws of its jurisdiction of organization and is duly qualified as a
foreign corporation and in good standing in all jurisdictions in which the nature of its activities requires such qualification.
The Company further represents to Chord: (1) that it has full power and authority to carry on its business as presently or proposed
to be conducted and to enter into and perform its obligations under this Agreement; (2) that this Agreement has been duly authorized
by all necessary corporate actions; and (3) that this Agreement constitutes the valid and binding obligation of the Company, enforceable
against the Company in accordance with its terms (except as such enforcement may be limited by bankruptcy, creditors’ rights
laws or general principles of equity). Chord represents that it is validly existing under the laws of its jurisdiction of organization.
Chord further represents to the Company: (1) that it has full power and authority to enter into and perform its obligations under
this agreement; and (2) that this agreement constitutes the valid and binding obligation of Chord, enforceable against Chord in
accordance with its terms (except as such enforcement may be limited by bankruptcy, creditors’ rights laws or general principles
of equity).

 

Section 3.  Advisory Fees.
Chord will invoice the Company for actual time incurred in performing the services hereunder, at the following rates: $350 for
partners/senior managing directors, $250 for directors and $100 for associates. Advisory Fees shall be payable monthly within 30
days after each month end during the engagement period. At no time shall Chord invoice Company in excess of $5,000 dollars in any
individual month without notifying Company and receiving express written approval from Company.

 

Section 4.  Expenses. In
addition to all other fees payable to Chord hereunder, the Company hereby agrees to reimburse Chord for all reasonable out-of-pocket
expenses incurred in connection with the performance of services hereunder. No individual 

 

    	Confidential	 	Page 1

     

    

 

  

 

 

expenses over $50 per month will be expended
without the prior written approval of the Company.

 

Section 5. Confidentiality.
From time to time during the term of this agreement, the Company may disclose or make available to Chord information about its
business affairs, finances, customers, products, services, technology, intellectual property, trade secrets, third-party confidential
information and other sensitive or proprietary information, whether orally or in written, electronic or other form or media (collectively,
“Confidential Information”). During the Engagement Period, and for a period of five (5) years thereafter, Chord shall:
(a) protect and safeguard the confidentiality of the Confidential Information with at least the same degree of care as Chord would
protect its own Confidential Information, but in no event with less than a commercially reasonable degree of care; (b) not use
the Confidential Information, or permit it to be accessed or used, for any purpose other than to perform its obligations under
this agreement; and (c) not disclose any such Confidential Information to any person or entity other than its employees on a need
to know basis who are participating in this engagement, are advised of the confidentiality thereof and who are subject to maintain
the confidentiality thereof. In the event that Chord or its representative is required by law or legal process to disclose any
Confidential Information, Chord will, to the extent legally permitted, provide Company with prompt written notice of such requirement
so that Company may seek an appropriate protective order or confidential treatment. If in the absence of a protective order or
confidential treatment, Chord or its representative is required by law or legal process to disclose Confidential Information, Chord
shall use commercially reasonable efforts to limit such disclosure to that portion of the Confidential Information that Chord or
its representative is legally required to disclose. In such case, Chord or its representative will exercise commercially reasonable
efforts to obtain assurance that confidential treatment will be accorded such Confidential Information.

 

Section 6.  Indemnification.
Each of the Company and Chord agrees to defend, indemnify and hold the other and its respective affiliates, stockholders, directors
officers, agents, employees, successors and assigns (each an “Indemnified Person”) harmless from and
against any and all liabilities, obligations, losses, damages, penalties, actions, judgments, suits, costs, expenses and disbursements
of any kind whatsoever (including, without limitation, reasonable attorneys’ fees) which arise from the Company’s or Chord’s (as
the case may be) breach of its obligations hereunder or any representation or warranty made by it herein. It is further agreed
that the foregoing indemnity shall be in addition to any rights that either party may have at common law or otherwise, including,
but not limited to, any right to contribution. Notwithstanding the foregoing, the indemnifying party is not obligated to indemnify,
hold harmless or defend any Indemnified Person against any Claims (whether direct or indirect) if and to the extent such Claims
arise out of or result from, in whole or in part, the:   (a) negligence or more culpable act or omission (including
recklessness or willful misconduct) of an Indemnified Person, or (b)

 

    	Confidential	 	Page 2

     

    

 

  

 

 

bad faith failure to materially comply with any of the obligations set
forth in this agreement of an Indemnified Person.

 

Section 7.  Termination of
Agreement, (a) Subject to paragraph (b) below, either party may terminate this Agreement and Chord’s engagement hereunder,
with or without cause, upon 30 days written notice given to the other party at any time during the Engagement Period hereunder.
In such event, all compensation accrued to Chord prior to such cancellation, whether in the form of Advisory Fees, reimbursement
for expenses or otherwise, will become due and payable promptly upon such termination and Chord shall be relieved of any and all
further obligation to provide any services hereunder.

 

(b) Notwithstanding
anything to the contrary herein contained, Sections 4, 5, 6, 7, 8, 9, 10, 11 and 12 shall survive any termination or breach of
this agreement by either party.

 

Section 8. Severability. In
case any provision of this letter agreement shall be invalid, illegal, or unenforceable, the validity, legality and enforceability
of the remaining provisions shall not be affected or impaired thereby.

 

Section 9. Consent to Jurisdiction.
This agreement shall be governed and construed in accordance with the laws of the State of California without regard to conflicts
of laws principles.

 

Section 10. Other Services.
If the Company desires additional services not provided for in this agreement, any such additional services shall be covered by
a separate agreement between the parties hereto.

 

Section 11. Entire Agreement.
This letter agreement contains the entire agreement of the Company and Chord, and supersedes any and all prior discussions and
agreements, whether oral or written, with respect to the matters addressed herein.

 

Section 12. Counterparts. This
letter agreement may executed in two or more counterparts, each of which shall be considered an original and all of which, taken
together, shall be considered as one and the same instrument.

 

    	Confidential	 	Page 3

     

    

 

  

 

 

Please evidence your acceptance of the provisions of this
letter by signing below and returning a copy to Chord Advisors, LLC.

 

	Very truly yours,	 
	 	 
	 	/s/ Sam Lynn 	 
	 	Sam Lynn 	 
	 	Managing Director 	 
	 	Chord Advisors, LLC	 

 

ACCEPTED AND AGREED

AS OF THE DATE FIRST ABOVE WRITTEN:

 

	By:	/s/ Andrew Ritter 	 
	 	Andrew Ritter 	 
	 	Founder & President 	 
	 	Ritter Pharmaceuticals, Inc.	 

   

    	Confidential	 	Page 4zayo-ex102_510.htm

Exhibit 10.2

November 9, 2015

 

[Participant Name]

[Address]

[Address]

 

 

Re:Notice of Waiver Pursuant to Section 3.1(d) of the Stockholders Agreement

Dear Participant:

Zayo Group Holdings, Inc. (the “Company”) is sending this notice to you as a party to the Stockholders Agreement between the Company and each Participant named therein, dated as of October 22, 2014, as amended by that certain First Amendment to Stockholders Agreement, dated as of September 17, 2015 (the “Stockholders Agreement”).  Capitalized terms used but not defined herein shall have the meanings assigned to them in the Stockholders Agreement.

Pursuant to Section 3.1(d) of the Stockholders Agreement, the Company hereby waives any and all of the restrictions set forth in Article III of the Stockholders Agreement (Transfers/Certain Covenants) effective as of November 16, 2015 (the “Effective Date”), including without limitation all restrictions on Transfer of Equity Securities by Participants, and shortens the Transfer Restriction Period such that it will lapse upon the Effective Date.  

Notwithstanding the above, the covenants set forth in Section 3.1(g) of the Stockholders Agreement are neither waived nor shortened and shall remain in place, such that until October 23, 2016, if any Equity Securities are distributed or otherwise Transferred by a Participant to its members, limited partners or other equity holders, such Participant shall provide the Company with written notice within 24 hours after such distribution or transfer.

For the avoidance of doubt, except as provided in the foregoing paragraph, the Transfer Restriction Period shall terminate and all other provisions of Article III in the Stockholders Agreement shall lapse and be of no further force and effect as of the Effective Date. 

Except as expressly waived or shortened by this Notice, the provisions of the Stockholders Agreement are, and will remain, unmodified and in full force and effect.

Sincerely,

 

Zayo Group Holdings, Inc.

	
By:
	
 /s/ Dan Caruso
Name: Dan Caruso
Title:  Chief Executive Officer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00251-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00251-of-00352.parquet"}]]